As posted late last week, India's Department of Industry Policy and Promotion (DIPP) proposed changing compulsory licensing to ensure drug availability and affordability in the country. This action is arising out of fears by some that the India Pharma Industry is becoming rapidly consolidated amongs larger firms and in particular multi-nationals. The result has been a rapid rise in exported drugs -- from 18% of revenues in 94-95 to more than 52% in 08-09. Foreign owners now account for 3 of the top 10 Indian drug companies.
Posted by Bruce Lehr August 30th 2010.